Under GST, ONGC Will Have To Ramp Up Production Spending By Rs 2,500 Crore
Oil and Natural Gas Corporation Ltd. (ONGC) will have to increase its production spending under the Goods and Services Tax regime (GST) since fuel does not come under its ambit.
The oil and gas major will have to bear the burden of an “additional Rs 2,500 crore hit unless crude oil and gas comes within GST,” AK Srinivasan, director of finance at ONGC said at a media briefing on Tuesday. Explaining the hit Srinivasan said, under GST, the company's survey costs will rise, as will the upstream oil and gas cost - to Rs 6,500 crore from Rs 4,000 crore currently.
The management also outlined its plans to reduce import dependence over the next five years. The KG-DWN-98/2 in the deep waters of Krishna-Godavari eastern offshore, the Gujarat State Petroleum Corp.'s (GSPC) Deendayal west field and Vasistha & S-1 fields will together account for 70 percent of the volume of western offshore purchases, said Dinesh Sarraf, chairman and managing director (CMD) of ONGC. Currently, the country imports half of its natural gas needs.
Elaborating on his plans for the development of the KG-DWN-98/2 block, Sarraf said, cluster 2 of the project will start gas production by June 2019 and oil production by March 2020, accounting for 70 percent of the company's oil and 27 percent of its gas production at its peak level. Cluster 3, which is deeper than cluster 2, will add another 40 percent to the company's gas production, he said.
The ambitious KG-DWN-98/2 block was budgeted to cost Rs 34,000 crore by the company's board. Sarraf told reporters that the project, which is stated to add 88,870 barrels of oil per day and 47 million cubic metres of gas, is being closely monitored and will be delivered as per the stipulated schedule.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.